Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
about
Angioplasty versus bare metal stenting for superficial femoral artery lesionsFeasibility and Clinical Outcomes of Peripheral Drug-Coated Balloon in High-Risk Patients with Femoropopliteal DiseaseCritical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stentProlonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcomePeripheral arterial disease: a literature review.Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.Early results with LifeStent implantation in RESILIENT and non-RESILIENT inclusion criteria patients.Endovascular intervention for peripheral artery disease.Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC SteeringA budget impact model for paclitaxel-eluting stent in femoropopliteal disease in FranceDurable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized TrialEconomic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.Clinical impact and risk stratification of balloon angioplasty for femoropopliteal disease in nitinol stenting era: Retrospective multicenter study using propensity score matching analysisA single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention.Drug-coated balloons for coronary and peripheral interventional procedures.An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013.Short-term Results of the RAPID Randomized Trial of the Legflow Paclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of Intermediate and Long Superficial Femoral Artery Lesions.Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.The endovascular approach for in-stent restenosis in femoropopliteal disease.Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).Short and long-term results after endovascular management of vascular complications during transfemoral aortic valve implantation.How should recent endovascular trials for femoropopliteal artery disease be interpreted?Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.Evolution of patency rates of self-expandable bare metal stents for endovascular treatment of femoro-popliteal arterial occlusive disease: Does stent design matter?Superficial Femoral Artery Intervention: Creating an Algorithmic Approach for the Use of Old and Novel (Endovascular) Technologies.Commentary: Future directions of superficial femoral artery stenting technology in the drug-coated balloon era.The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use.Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.Value of C-Arm Computed Tomography to Evaluate Stent Deployment During Femoro-Popliteal Revascularization.A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.Current Status of Drug-Eluting Stents and Drug-Eluting Balloons for the Superficial Femoral Artery.
P2860
Q24193807-9F7CF373-5056-4E10-9305-1B41273E36D3Q28551128-5FD588F7-1ACA-4D3F-BE10-2C792DD27B04Q33710114-2A1B5108-62D5-474A-BA27-6286CF2206F1Q33826534-A5880449-E3F4-42CA-9D87-0BC19B54CF56Q34451668-6143E6E5-3D72-4AC2-A9D5-A94EE7B6E941Q35679312-90CD94A5-45EF-461C-9415-20ECE2B1BC4EQ35765692-CAA94517-08AB-4C8C-8BC1-4D18C23ACB42Q35857220-9192D1DA-2A99-4D5F-933E-231843D72993Q36106277-56520751-3617-44F0-9BDF-B6A3D1B55363Q36405390-9771B6E8-1525-46AF-AB9C-30DADF86F6D4Q36678307-91B8F8A4-EA14-4B70-88B3-DCD329661139Q36774583-4892659D-521A-408B-A194-13349DD2B9D9Q36920052-490CE5F2-BD7E-4347-BF30-7CCD63BCD51AQ37129580-21A64698-A92A-4221-837A-0474BAC67DE6Q37257331-C238793B-CDC7-412B-B817-945AC0F2BA3CQ37333232-E91218C5-64C2-4EA1-BC33-BAA17F2C79BAQ38028877-17F5BB7A-76ED-4DDF-93B0-ECFDC6A0B2FDQ38179363-2DAEAF3D-9A81-4BBB-A910-FDE089C0D735Q38208287-7E8B4C8A-ABB9-4166-8F64-0E0B2FC7C03CQ38211926-698DBEF3-3112-43F3-8DDE-22572D9B24FFQ38239197-57574B4D-7B13-4305-8450-61353EF88465Q38372419-38A41B3B-7A22-4CA0-B6D4-5ED97844F473Q38373588-9ED25370-485C-4FB1-8D9B-F0976EE025E5Q38374297-27FFAD3F-5591-47E9-AC36-7B8F45147998Q38392409-4F083C84-FF2F-40BA-A5A9-D9253A9CAC38Q38395394-7D9E02A5-D740-44DC-8A87-8351DD1275FAQ38414835-D1BCFF9D-34DF-4CA1-9648-9C56D2D19380Q38560311-BC78470F-A0D5-4BA3-9BEB-DBE961CAC313Q38680555-161DC060-41C7-4CAA-9633-2EFF1056BC88Q38934274-79BC0E72-E27E-4A9B-A0BE-FCF2DE33FAB3Q38968545-3F663F54-6925-4024-8B67-CCFBC32CBCF0Q38975005-E1341861-86EF-4302-8D58-9DED40CD5C81Q38975104-62CBC7C5-B070-4841-85B8-B3031CD87470Q39028708-FEF43B21-C9D1-4CE8-9AF3-2A62FDA4DD50Q39167858-F53D3658-90C1-4476-8225-A5C7981EA2A6Q39206048-9FAC110C-0AA1-47CC-B850-503639BC47F5Q39435685-2A7C0DA1-03E4-4704-BE24-02CFEB4B548DQ40279276-986CB75C-2985-4E43-9E60-57FAE5841D4AQ40361474-2291BBD8-799E-404B-99C3-4B66C5CE8330Q41965693-8DD459F9-EF93-44D9-A4FF-9CEA04215049
P2860
Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Nitinol stent implantation vs. ...... he RESILIENT randomized trial.
@en
Nitinol stent implantation vs. ...... he RESILIENT randomized trial.
@nl
type
label
Nitinol stent implantation vs. ...... he RESILIENT randomized trial.
@en
Nitinol stent implantation vs. ...... he RESILIENT randomized trial.
@nl
prefLabel
Nitinol stent implantation vs. ...... he RESILIENT randomized trial.
@en
Nitinol stent implantation vs. ...... he RESILIENT randomized trial.
@nl
P2093
P356
P1476
Nitinol stent implantation vs. ...... he RESILIENT randomized trial.
@en
P2093
Alexandra Lansky
Annie Y Cao
Barry T Katzen
Dierk Scheinert
Ecaterina Cristea
Gary Ansel
Jeffrey Carpenter
Jeffrey Goldstein
Johannes Lammer
John R Laird
P356
10.1583/11-3627.1
P577
2012-02-01T00:00:00Z